Examkin

Question

Difficulty: HardDiagnostic Workup and Test Sequencing

A 38-year-old woman is evaluated in the outpatient clinic for a 2-month history of palpitations, increased sweating, and an unintended weight loss of 4 kg (8.8 lb). She has no significant past medical history and takes no medications. Vital signs include a blood pressure of 135/85 mm Hg and a heart rate of 112/min. Physical examination reveals a mild fine tremor of the outstretched hands and a palpable, firm, non-tender nodule in the right lobe of the thyroid gland. There is no cervical lymphadenopathy. A targeted ultrasound of the neck demonstrates a 2.2-cm solid, markedly hypoechoic nodule in the right thyroid lobe with microcalcifications and irregular margins. Laboratory studies show:

TestResultReference Range
Thyroid-stimulating hormone (TSH)<0.01 µU/mL0.4 - 4.0 µU/mL
Free thyroxine (T4)2.9 ng/dL0.9 - 1.7 ng/dL

Which of the following is the most appropriate next step in the diagnostic workup?

  1. Radionuclide thyroid scintigraphyAnswer
  2. B
    Fine-needle aspiration biopsy of the nodule
  3. C
    Computed tomography of the neck with intravenous contrast
  4. D
    Measurement of serum thyroid-stimulating immunoglobulins
  5. E
    Measurement of serum calcitonin level

Answer

Radionuclide thyroid scintigraphy
According to standard clinical guidelines, the initial diagnostic evaluation of a thyroid nodule >1 cm begins with measuring serum TSH. If the TSH is normal or elevated, the next step is fine-needle aspiration (FNA) biopsy, guided by sonographic risk criteria. However, if the TSH is subnormal, the most appropriate next step is radionuclide thyroid scintigraphy (using I-123 or Tc-99m) to determine if the nodule is hyperfunctioning ('hot'), isofunctioning ('warm'), or nonfunctioning ('cold'). This critical sequencing step must be followed even if the nodule demonstrates highly suspicious sonographic features, such as microcalcifications, irregular margins, and marked hypoechogenicity. Hyperfunctioning nodules are virtually never malignant. Performing an FNA on a hyperfunctioning nodule is contraindicated because the active follicular cells often display significant pleomorphism and atypia, which can mimic carcinoma and result in unnecessary surgical intervention.

Step-by-Step Solution

1
Analyze the laboratory data in the context of the clinical presentation.
The patient has overt primary thyrotoxicosis (suppressed TSH, elevated free T4).
Establishing the biochemical functional status of the thyroid gland is the first step in the algorithm for evaluating a thyroid nodule.
2
Evaluate the ultrasound findings against the biochemical status.
The ultrasound shows a >1 cm nodule with highly suspicious malignant features (hypoechoic, microcalcifications, irregular margins). However, the TSH is suppressed.
Understanding the interplay between nodule morphology and biochemical function determines the correct diagnostic sequence.
3
Apply the evidence-based diagnostic algorithm for thyroid nodules.
Guidelines dictate that if a nodule is >1 cm and the TSH is subnormal, radionuclide scintigraphy must be performed next, regardless of how suspicious the ultrasound features appear.
A hyperfunctioning ('hot') nodule is virtually never malignant. Fine-needle aspiration is deferred because hyperplastic cells in a toxic adenoma can exhibit architectural atypia, leading to false-positive cytology and unnecessary surgery.

Key Concept

In the evaluation of a thyroid nodule, a suppressed TSH level dictates that radionuclide scintigraphy is the next appropriate diagnostic step, even in the presence of highly suspicious sonographic features.
Estimated Time:1m 30s
Rate this question

Topics

Diagnostic Workup and Test Sequencing

More questions from this topic